2m 2m 2m 2m 2m 2m 2m
Silexion (SLXN)
NASDAQ
$3.13-$0.10 (-3.16%)
Price as of Nov 12, 2026 8:24 AM EST- N/AMarket Cap
- -99.54%1-Year Change
- BiotechnologyIndustry
Silexion (SLXN)
$3.13-$0.10 (-3.16%)
SLXN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.23 | ||
Change | +$0.62 (+23.58%) | ||
Open | $2.80 | ||
High | $3.89 | ||
Low | $2.71 | ||
Previous Close | $0.11 | ||
Volume | 293,350 | ||
30-Day Average Volume | 60,589 | ||
1-Week Change | -12.32% | ||
1-Month Change | -37.29% | ||
1-Year Change | -99.54% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 5.6M | ||
Total Assets | $4.2M | ||
Market Cap | N/A | ||
Enterprise Value | N/A | ||
Period: QTR TTM FY | |||
Revenue | $14,000.00 | ||
Net Income | -$3.6M | ||
Free Cash Flow | -$2.9M | ||
EBIT | -$3.5M | ||
EBITDA | -$3.5M | ||
Net Working Capital | -$235,000.00 | ||
EPS | $124.08 | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | 408 | ||
P/E | 0 | ||
PEG | 0 | ||
Price/Free Cash Flow | -6 | ||
Price/Operating Cash Flow | -6 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 24 | ||
Last Split Date | 11/11/2026 | ||
Earnings & Revenue